Abstract:Background: Recent reports indicate that a subgroup of tumor cells named cancer stem cells (CSCs) or tumor initiating cells (TICs) are responsible for tumor initiation, growth and drug resistance. This subgroup of tumor cells has self-renewal capacity and could differentiate into heterogeneous tumor cell populations through asymmetric proliferation. The idea of CSC provides informative insights into tumor initiation, metastasis and treatment. However, the underlying mechanisms of CSCs regulating tumor behaviors are unclear due to the complex cancer system. To study the functions of CSCs in the complex tumor system, a few mathematical modeling studies have been proposed. Whereas, the effect of microenvironment (mE) factors, the behaviors of CSCs, progenitor tumor cells (PCs) and differentiated tumor cells (TCs), and the impact of CSC fraction and signaling heterogeneity, are not adequately explored yet.Methods: In this study, a novel 3D multi-scale mathematical modeling is proposed to investigate the behaviors of CSCsin tumor progressions. The model integrates CSCs, PCs, and TCs together with a few essential mE factors. With this model, we simulated and investigated the tumor development and drug response under different CSC content and heterogeneity.Results: The simulation results shown that the fraction of CSCs plays a critical role in driving the tumor progression and drug resistance. It is also showed that the pure chemo-drug treatment was not a successful treatment, as it resulted in a significant increase of the CSC fraction. It further shown that the self-renew heterogeneity of the initial CSC population is a cause of the heterogeneity of the derived tumors in terms of the CSC fraction and response to drug treatments.Conclusions: The proposed 3D multi-scale model provides a new tool for investigating the behaviors of CSC in CSC-initiated tumors, which enables scientists to investigate and generate testable hypotheses about CSCs in tumor development and drug response under different microenvironments and drug perturbations.

Constraint-Based Modeling and Simulation of Cell Populations

Cancer Stem Cell, Niche and EGFR Decide Tumor Development and Treatment Response: A Bio-Computational Simulation Study.

Simulating the Dynamic Intra-Tumor Heterogeneity and Therapeutic Responses

Quark-gluon vertex with an off-shell O(a)-improved chiral fermion action

Quantitative constraint-based computational model of tumor-to-stroma coupling via lactate shuttle

Bridging Scales: a Hybrid Model to Simulate Vascular Tumor Growth and Treatment Response

An agent-based modelling framework for tumour growth incorporating mechanical and evolutionary aspects of cell dynamics

Toward Modeling Metabolic State from Single-Cell Transcriptomics.

A stochastic model for tumor heterogeneity

Simulating brain tumor heterogeneity with a multiscale agent-based model: Linking molecular signatures, phenotypes and expansion rate

Programmable models of growth and mutation of cancer-cell populations

Modelling the order of driver mutations and metabolic mutations as structures in cancer dynamics

A multiscale cell‐based model of tumor growth for chemotherapy assessment and tumor‐targeted therapy through a 3D computational approach

An In Silico Perspective

Coupling Cell Kinetics with Metabolism, Signaling Networks, and Biomechanics as Plug-in Component Models of a Cancer Digital Twin

Modeling of Tumor Growth with Input from Patient-Specific Metabolomic Data

Towards personalized computer simulations of breast cancer treatment

A 3D Multiscale Model of Cancer Stem Cell in Tumor Development.

Towards Inverse Modeling of Intratumoral Heterogeneity

Modeling multi-mutation and drug resistance: analysis of some case studies

Stochastic multi-scale models of competition within heterogeneous cellular populations: simulation methods and mean-field analysis